Skip to main content

News

  • AddRemove
  • Build a Report 
Media Coverage

Generic-Reglan Suits Doomed By Catch-22, 6th Circ. Says

2 December 2013
Law360
Mayer Brown is mentioned as representing Schwarz Pharma Inc. and Alaven Pharmaceuticals LLC in an article reporting that the US Circuit Court of Appeals for the Sixth Circuit refused to revive seven lawsuits alleging a generic version of the digestion medication Reglan caused users to develop a serious neurological condition.

Related Information

  • Related People
    Henninger S. Bullock
    T +1 212 506 2528
    Andrew J. Calica
    T +1 212 506 2256
The Build a Report feature requires the use of cookies to function properly. Cookies are small text files that are placed on your computer by websites that you visit. They are widely used in order to make websites work, or work more efficiently. If you do not accept cookies, this function will not work. For more information please see our Privacy Policy

You have no pages selected. Please select pages to email then resubmit.